kresmion.
Pull a receipt

XTL Biopharmaceuticals LTD (XTLB)

Sector
Healthcare
Industry
Biotechnology
Last price
$1.55
As of

Kresmion compiles this page from XTLB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

XTL BIOPHARMACEUTICALS LTD (XTLB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-14.

As of . Source: SEC EDGAR filings for XTLB. Method and limitations.

COMPANY DOSSIER

See the full XTLB dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for XTLB on one page. Preview it with sample data, then open it live with a free account.

Preview the XTLB dossier

Active events for XTLB

No recent events on XTLB in the last 180 days.

FREE, NO ACCOUNT

Every event on XTLB, as it fires

New filings, 13F moves and cross asset events on XTLB land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, XTLB

Going concern statement

XTLB's 20-F filed Jun 30, 2026 states:

Management has concluded that there is substantial doubt about our ability to continue as a going concern which could prevent us from obtaining new financing on reasonable terms or at all.

Read the 20-F on SEC EDGAR Every company with a going concern statement

More data on XTLB

XTLB mentioned in Kresmion daily briefs

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in XTLB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on XTLB in the last 180 days.

Upstream: SEC EDGAR filings for XTLB

Kresmion, "XTL BIOPHARMACEUTICALS LTD (XTLB) institutional holdings and SEC filings", data as of 2026-10-14, https://kresmion.com/research/XTLB. Upstream data: SEC EDGAR filings for XTLB.

Link to this data (HTML):

<a href="https://kresmion.com/research/XTLB">XTL BIOPHARMACEUTICALS LTD (XTLB) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow XTLB on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to XTLB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the XTLB dossier
Share

The XTLB intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.